Press Release: Abacus dx Announces Partnership with Response Biomedical
Abacus dx Announces Commercial Partnership with Response Biomedical in Australia & New Zealand’s Clinical Market Sector
Brisbane, 6th November 2024
06Nov
05Jul
Press Release: Abacus dx Announces Partnership with Epredia
Abacus dx Announces Commercial Partnership with Epredia in Australia & New Zealand’s Clinical Market Sector
Brisbane, 1st July 2024
20Jun
Press Release: Abacus dx Announces Partnership with Roche in Australia’s Life Science sector
Abacus dx Announces Commercial Partnership with Roche in Australia’s Life Science sector
Brisbane, 1st June 2024
11Aug
Press Release: Abacus dx Announces Partnership with Nikon Microscopes for Australia & New Zealand Pathology Markets
Products are for professional/laboratory use only.
Abacus dx Pty Ltd Announces Partnership with Nikon Microscopes for Australia & New Zealand Pathology Markets
Brisbane, 11th August 2023
24Aug
ASCIA 2022 Conference – Abacus dx sponsored speaker session Wednesday 31 August
Abacus dx are pleased to announce our sponsored speaker session at ASCIA will be held on Wednesday 31 August at 8:10am via a virtual presentation.
02Feb
Abacus dx COVID-19 Response
Products are for professional/laboratory use only.
In the light of the rapidly developing COVID-19 pandemic, we would like to provide the following information about the steps Abacus dx has taken in response to the virus outbreak:
03Feb
Press Release: Abacus ALS & Diagnostic Solutions are now Abacus dx
Products are for professional/laboratory use only.
Abacus ALS & Diagnostic Solutions are now Abacus dx
Brisbane, November 21, 2017, Abacus ALS Pty Ltd (Abacus ALS) and Diagnostic Solutions Pty Ltd (Diagnostic Solutions) today announced
03Feb
Abacus ALS acquired by Diploma PLC
Products are for professional/laboratory use only.
In recent times the shareholders of Abacus ALS have been exploring options to transition away from the current shareholding of the business. We are pleased to announce that Diploma PLC has acquired Abacus ALS, and the company will be included in the Diploma Healthcare Group.
03Feb
Abacus ALS raises $3,500 for the Paraplegic Benefit Fund
Products are for professional/laboratory use only.
Six months after commencing our “Walking for Wellness” challenge, Abacus ALS staff have recently reached our milestone of walking over 3,500 kilometres to raise money for the Paraplegic Benefit Fund (PBF). We started the challenge back in July 2016 with the aim to help our staff increase their wellness, through being more active, whilst also raising money for this worthy cause.